About Cellivery
Cellivery is a company based in Seoul (South Korea) founded in 2014. Cellivery has raised $6.26 million across 1 funding round from investors including Ildong Pharmaceutical and SBI Investment Korea. Cellivery operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Seoul, South Korea
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website cellivery.com
- Social LinkedIn
- Total Equity Funding$6.26M (USD)
in 1 rounds
- Latest Funding Round$6.26M (USD), Series A
May 2017
- InvestorsIldong Pharmaceutical
& 1 more
Funding Insights of Cellivery
Cellivery has successfully raised a total of $6.26M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.26 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.26M
- Total Rounds 1
- Last Round Series A — $6.26M
- First Round $6.26M
(May 2017)
- Investors Count 2
All 1 funding rounds of Cellivery with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2017 | $6.26M | Series A | – | Ildong Pharmaceutical, SBI Investment Korea | – |
2 investors in total: 2 institutional.
Investors in Cellivery
Cellivery has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Ildong Pharmaceutical and SBI Investment Korea.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sector-agnostic VC firm investing in geographies such as South Korea | 1986 | sbik.co.kr | Seoul, South Korea | |
Pharmaceuticals and ingredients are manufactured for various health needs. | 1941 | ildong.com | Seoul, South Korea |
Investor details for Cellivery
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Cellivery
3 dated milestones of Cellivery across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Cellivery is founded.
- Funding First funding round of $6.3M.
- IPO Lists on the stock exchange (IPO).
Competitors of Cellivery
Cellivery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| lifeminetx.com | 2016 | Cambridge, United States | $300.07M | 85 | Developer of novel drugs from fungi via genome mining and recombinant overexpression |
Detailed competitors of Cellivery
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cellivery
The website of Cellivery (cellivery.com) receives about 5.6K visits a month.
- Monthly visits5.6K
▼ 31.8% vs previous month
Websites whose visitors overlap most with Cellivery. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| paxnet.co.kr | 100% | – | #89,085 | View details | |
thinkpool.com | thinkpool.com | 70% | – | #52,599 | – |
finance.daum.net | finance.daum.net | 60% | – | #15,246 | – |
Latest news on Cellivery
Complete news archive for Cellivery
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Cellivery
10 companies that operate in the same segment as Cellivery (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cellivery
Cellivery was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Cellivery is headquartered in Seoul, South Korea.
Cellivery is a funded company, having raised a total of $6.26M across 1 funding round to date. The company's 1st funding round was a Series A of $6.26M, raised on May 2017.
Cellivery was founded in 2014 in Seoul, South Korea, as a biotech firm focused on protein-based drug discovery. The companys platform technology is applied to deliver therapeutic macromolecules into mammalian cells using cell-penetrating peptides, including proprietary advanced transduction domains. Operations center on linking these peptides to therapeutic agents for biologic drugs targeting cancer and other diseases, with 12 candidates currently in preclinical development.
Cellivery's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Cellivery has 2 investors. Key investors include Ildong Pharmaceutical, and SBI Investment Korea.